Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Tesla, Nvidia, Ford, C3.ai, Kala Pharma: Why These 5 Stocks Are Drawing Investors' Attention Today

Published 06/03/2023, 01:06
Updated 06/03/2023, 02:10
© Reuters.  Tesla, Nvidia, Ford, C3.ai, Kala Pharma: Why These 5 Stocks Are Drawing Investors' Attention Today
F
-
NVDA
-
TSLA
-
IXIC
-
KALA
-
NVDC34
-

Benzinga - U.S. markets ended in the green on Friday with major indices gaining over 1% as investors and traders weighed in on the fall in U.S. Treasury yields. The Nasdaq Composite closed 1.97% higher while the S&P 500 rose 1.61%. The Dow Jones gained 1.17%. Meanwhile, the following are the five stocks that are drawing investors' attention:

1. Tesla Inc (NASDAQ:TSLA): Shares of Tesla closed 3.61% higher on Friday. The company said it is recalling 3,470 units of 2022-2023 Model Y vehicles due to issues with second-row seats. One or more bolts that secure the seat back frames to the lower seat frame may not have been securely tightened as per specifications, the company said in a filing with the National Highway Transport Safety Administration.

Also Read: Everything You Need To Know About Tesla Stock

2. NVIDIA Corporation (NASDAQ:NVDA): Shares of Nvidia closed 2.47% higher on Friday. The company's plans to sell technology to China’s Huawei could be unsuccessful if the U.S. government moves forward with a proposal to further halt shipments to the blacklisted company, Reuters reported, citing a draft report by a government contractor.

3. Ford Motor Co (NYSE:F): Shares of the company closed 4.22% higher on Friday. The company said it was studying ways to increase the output of gasoline-powered and hybrid F-150 trucks at a Michigan factory as part of a broader plan to expand the production of many models, according to a Reuters report.

4. C3.ai Inc (NYSE:AI): Shares of the company ended 33.65% higher on Friday. It reported a quarterly loss of 6 cents per share, ahead of the expected 22-cent loss. Wedbush analyst Dan Ives maintained a ‘Neutral' rating on the stock but raised the price target to $24. Ives said that with increased demand for its AI products, C3.ai was experiencing tailwinds in the market.

5. Kala Pharmaceuticals Inc (NASDAQ:KALA): Shares of the company closed 64.7% higher on Friday. For the quarter ended December 31, 2022, Kala reported a net loss of $12.8 million compared to a net loss of $47.6 million for the same period in 2021.

Read Next: Is Inflation Going To Force Costco To Raise The Price Of Its Famous Hot Dog?

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.